Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway

MLA

Razan Abou Ziki, et al. Men1 Disruption in Nkx3.1-Deficient Mice Results in ARlow/CD44+ Microinvasive Carcinoma Development with the Dysregulated AR Pathway. Feb. 2021. EBSCOhost, https://doi.org/10.1038/s41388-020-01589-1⟩.

APA

Razan Abou Ziki, Romain Teinturier, Virginie Firlej, Nicolas Gadot, Muriel Le Romancer, Samuele Gherardi, Myriam Decaussin-Petrucci, Virginie Vlaeminck-Guillem, Remy Bonnavion, Philippe Bertolino, F. Vacherot, Yakun Luo, Isabelle Goddard, & Chang Xian Zhang. (2021). Men1 disruption in Nkx3.1-deficient mice results in ARlow/CD44+ microinvasive carcinoma development with the dysregulated AR pathway. https://doi.org/10.1038/s41388-020-01589-1⟩

Chicago

Razan Abou Ziki, Romain Teinturier, Virginie Firlej, Nicolas Gadot, Muriel Le Romancer, Samuele Gherardi, Myriam Decaussin-Petrucci, et al. 2021. “Men1 Disruption in Nkx3.1-Deficient Mice Results in ARlow/CD44+ Microinvasive Carcinoma Development with the Dysregulated AR Pathway,” February. doi:10.1038/s41388-020-01589-1⟩.